Different mechanisms mediating the decrease of cerebellar cGMP elicited by haloperidol and diazepam.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D006152:Cyclic GMP / Q000378:metabolism*; D003975:Diazepam / Q000494:pharmacology*; D006220:Haloperidol / Q000494:pharmacology*; D006246:Harmaline / Q000494:pharmacology; D007538:Isoniazid / Q000494:pharmacology; D007700:Kinetics; D051381:Rats; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D005680:gamma-Aminobutyric Acid; D006246:Harmaline; D006152:Cyclic GMP; D006220:Haloperidol; D001058:Apomorphine; D003975:Diazepam; D007538:Isoniazid